St. Jude Gala Spotlights Sickle Cell Research Amid Rising Awareness Efforts
Event summary
- St. Jude Children’s Research Hospital hosts 'A Legacy of Equity' gala in Chicago on June 20, 2026, coinciding with World Sickle Cell Day.
- Event highlights St. Jude’s longstanding commitment to sickle cell disease research, including its first grant in 1958 and leading one of the largest sickle cell programs in the U.S.
- Gala features a patient and family testimonial, signature cocktail hour, curated dinner, and live entertainment.
- St. Jude has contributed to major advances in sickle cell disease treatment and continues to explore new curative therapies.
The big picture
St. Jude’s focus on sickle cell disease research aligns with broader industry trends toward specialized pediatric care and precision medicine. The gala underscores the hospital’s role in driving awareness and funding for under-researched diseases, positioning it as a key player in the fight against life-threatening pediatric conditions. With a history of breakthroughs, St. Jude’s continued investment in sickle cell research could set new standards for treatment and cure.
What we're watching
- Research Progress
- The pace at which St. Jude advances new curative therapies for sickle cell disease will determine its leadership in pediatric research.
- Funding Dynamics
- Whether St. Jude can sustain its research momentum through continued donor support and sponsorships.
- Awareness Impact
- How the gala and similar events will affect global awareness and funding for sickle cell disease research.
Related topics